Published in Eur J Immunol on December 11, 2012
Carbon monoxide: present and future indications for a medical gas. Korean J Intern Med (2013) 0.95
The immunomodulatory role of carbon monoxide during transplantation. Med Gas Res (2013) 0.92
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res (2015) 0.90
Dendritic cell subsets in type 1 diabetes: friend or foe? Front Immunol (2013) 0.88
Haeme oxygenase signalling pathway: implications for cardiovascular disease. Eur Heart J (2015) 0.81
Targeting dendritic cell function during systemic autoimmunity to restore tolerance. Int J Mol Sci (2014) 0.80
Carbon monoxide exposure improves immune function in lupus-prone mice. Immunology (2013) 0.80
Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? Oncotarget (2016) 0.79
Carbon monoxide down-regulates α4β1 integrin-specific ligand binding and cell adhesion: a possible mechanism for cell mobilization. BMC Immunol (2014) 0.75
Knockout rats via embryo microinjection of zinc-finger nucleases. Science (2009) 12.33
Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol (2011) 8.45
Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity (2008) 6.08
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med (2010) 2.21
The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes (2008) 2.04
Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation (2005) 2.02
CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes (2007) 1.98
A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood (2007) 1.91
Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood (2005) 1.86
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood (2007) 1.83
Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention. Blood (2010) 1.63
Characterization of immunoglobulin heavy chain knockout rats. Eur J Immunol (2010) 1.63
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle. Mol Ther (2008) 1.63
Bispecific small molecule-antibody conjugate targeting prostate cancer. Proc Natl Acad Sci U S A (2013) 1.52
Generation of gene-specific mutated rats using zinc-finger nucleases. Methods Mol Biol (2010) 1.51
Lentiviral vectors that express UGT1A1 in liver and contain miR-142 target sequences normalize hyperbilirubinemia in Gunn rats. Gastroenterology (2010) 1.48
Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proc Natl Acad Sci U S A (2006) 1.47
IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells. Eur J Immunol (2007) 1.46
Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation (2005) 1.41
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest (2010) 1.40
A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles. Hum Gene Ther (2002) 1.37
Fms-like tyrosine kinase 3 ligand recruits plasmacytoid dendritic cells to the brain. J Immunol (2006) 1.32
CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase. J Clin Invest (2007) 1.23
Zinc-finger nucleases: a powerful tool for genetic engineering of animals. Transgenic Res (2009) 1.22
Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. FASEB J (2005) 1.21
Lack of immunotoxicity after regional intravenous (RI) delivery of rAAV to nonhuman primate skeletal muscle. Mol Ther (2009) 1.21
Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity. J Immunol (2009) 1.19
Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes. Eur J Immunol (2003) 1.16
Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev (2012) 1.11
Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice. J Immunol (2008) 1.10
Transgenic modifications of the rat genome. Transgenic Res (2005) 1.08
Macrophages expressing heme oxygenase-1 improve renal function in ischemia/reperfusion injury. Mol Ther (2010) 1.08
Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells. J Immunol (2006) 1.07
Rapid and accurate determination of zygosity in transgenic animals by real-time quantitative PCR. Transgenic Res (2002) 1.06
Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J Immunol (2010) 1.05
Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant (2002) 1.04
Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts. Am J Transplant (2005) 1.02
Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol Ther (2002) 1.01
Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients. J Immunol (2007) 1.01
Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases. FASEB J (2012) 1.00
Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med (2009) 1.00
Pronuclear DNA injection for the production of transgenic rats. Methods Mol Biol (2009) 0.95
Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function. Front Immunol (2013) 0.95
The C-type lectin-like receptor CLEC-1, expressed by myeloid cells and endothelial cells, is up-regulated by immunoregulatory mediators and moderates T cell activation. J Immunol (2009) 0.93
Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation. Transgenic Res (2005) 0.93
Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am J Transplant (2005) 0.93
Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients. J Immunol (2007) 0.92
Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer. Kidney Int (2004) 0.92
Easy and rapid method of zygosity determination in transgenic mice by SYBR Green real-time quantitative PCR with a simple data analysis. Transgenic Res (2006) 0.91
The elusive case for a role of mimicry in autoimmune diseases. Mol Immunol (2004) 0.90
Analysis by quantitative PCR of zygosity in genetically modified organisms. Methods Mol Biol (2010) 0.89
Immunoregulatory properties of heme oxygenase-1. Methods Mol Biol (2011) 0.89
Temporal analysis of cytokine gene expression during infiltration of porcine neuronal grafts implanted into the rat brain. J Neurosci Res (2002) 0.89
Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination. Transplantation (2004) 0.88
High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region. J Immunol (2013) 0.88
β2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells. J Immunol (2013) 0.88
Over-expression of heme oxygenase-1 by adenoviral gene transfer improves pregnancy outcome in a murine model of abortion. J Reprod Immunol (2005) 0.88
Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation. Transplantation (2008) 0.87
T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging. Radiology (2005) 0.87
Pdx-1 or Pdx-1-VP16 protein transduction induces beta-cell gene expression in liver-stem WB cells. BMC Res Notes (2009) 0.87
Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat. Mol Ther (2002) 0.87
CD8+ regulatory T cells in solid organ transplantation. Curr Opin Organ Transplant (2010) 0.87
Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells. Eur J Immunol (2013) 0.86
Effects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease. Parkinsons Dis (2011) 0.85
Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation (2005) 0.85
IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J Clin Invest (2015) 0.84
Limitations of IL-2 and rapamycin in immunotherapy of type 1 diabetes. Diabetes (2013) 0.84
Expression of heme oxygenase-1 in neural stem/progenitor cells as a potential mechanism to evade host immune response. Stem Cells (2012) 0.84
Differential sensitivity of endothelial cells of various species to apoptosis induced by gene transfer of Fas ligand: role of FLIP levels. Mol Med (2002) 0.84
Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemia. Angew Chem Int Ed Engl (2014) 0.84
Transmethylation in immunity and autoimmunity. Clin Immunol (2011) 0.84
HLA class I epitope discovery in type 1 diabetes. Ann N Y Acad Sci (2006) 0.84
The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection. J Immunol (2004) 0.84
Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig. Blood (2002) 0.83